154 related articles for article (PubMed ID: 19661369)
1. Efficiency of iloprost treatment for chemotherapy-associated osteonecrosis after childhood cancer.
Jäger M; Zilkens C; Westhoff B; Jelinek EM; Kozina G; Krauspe R
Anticancer Res; 2009 Aug; 29(8):3433-40. PubMed ID: 19661369
[TBL] [Abstract][Full Text] [Related]
2. Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.
Jäger M; Tillmann FP; Thornhill TS; Mahmoudi M; Blondin D; Hetzel GR; Zilkens C; Krauspe R
Arthritis Res Ther; 2008; 10(5):R120. PubMed ID: 18834533
[TBL] [Abstract][Full Text] [Related]
3. Joint preserving surgery for osteonecrosis and osteochondral defects after chemotherapy in childhood.
Werner A; Jäger M; Schmitz H; Krauspe R
Klin Padiatr; 2003; 215(6):332-7. PubMed ID: 14677098
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): an approach to cure? -- BME/AON and hyperbaric oxygen therapy as a treatment modality.
Bernbeck B; Christaras A; Krauth K; Lentrodt S; Strelow H; Schaper J; Janssen G; Mödder U; Göbel U
Klin Padiatr; 2004; 216(6):370-8. PubMed ID: 15565553
[TBL] [Abstract][Full Text] [Related]
5. Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL).
Kotecha RS; Powers N; Lee SJ; Murray KJ; Carter T; Cole C
Pediatr Blood Cancer; 2010 Jul; 54(7):934-40. PubMed ID: 20127847
[TBL] [Abstract][Full Text] [Related]
6. Relationships among severity of osteonecrosis, pain, range of motion, and functional mobility in children, adolescents, and young adults with acute lymphoblastic leukemia.
Marchese VG; Connolly BH; Able C; Booten AR; Bowen P; Porter BM; Rai SN; Hancock ML; Pui CH; Howard S; Neel MD; Kaste SC
Phys Ther; 2008 Mar; 88(3):341-50. PubMed ID: 18202079
[TBL] [Abstract][Full Text] [Related]
7. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.
Aricò M; Boccalatte MF; Silvestri D; Barisone E; Messina C; Chiesa R; Santoro N; Tamaro P; Lippi A; Gallisai D; Basso G; De Rossi G;
Haematologica; 2003 Jul; 88(7):747-53. PubMed ID: 12857552
[TBL] [Abstract][Full Text] [Related]
8. Efficiency of iloprost treatment for osseous malperfusion.
Jäger M; Zilkens C; Bittersohl B; Matheney T; Kozina G; Blondin D; Krauspe R
Int Orthop; 2011 May; 35(5):761-5. PubMed ID: 20306261
[TBL] [Abstract][Full Text] [Related]
9. [MRI of aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukemia].
Engelbrecht V; Scherer A; Bruder M; Körholz D; Mödder U
Rofo; 2000 Apr; 172(4):336-41. PubMed ID: 10961217
[TBL] [Abstract][Full Text] [Related]
10. Articulated hip distraction: a treatment option for femoral head avascular necrosis in adolescence.
Gomez JA; Matsumoto H; Roye DP; Vitale MG; Hyman JE; van Bosse HJ; Marangoz S; Sala DA; Stein MI; Feldman DS
J Pediatr Orthop; 2009 Mar; 29(2):163-9. PubMed ID: 19352242
[TBL] [Abstract][Full Text] [Related]
11. [Multifocal osteonecrosis in children and adolescents after polychemotherapy].
Raab P; Kühl J; Krauspe R
Z Orthop Ihre Grenzgeb; 1997; 135(5):444-50. PubMed ID: 9446438
[TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95.
Bürger B; Beier R; Zimmermann M; Beck JD; Reiter A; Schrappe M
Pediatr Blood Cancer; 2005 Mar; 44(3):220-5. PubMed ID: 15514916
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia.
Leblicq C; Laverdière C; Décarie JC; Delisle JF; Isler MH; Moghrabi A; Chabot G; Alos N
Pediatr Blood Cancer; 2013 May; 60(5):741-7. PubMed ID: 23002054
[TBL] [Abstract][Full Text] [Related]
14. Effect of Iloprost infusion on metabolism in critical limb ischemia, utilizing microdialysis. A pilot study.
Danielsson P; Metzsch C; Norgren L
Int Angiol; 2004 Sep; 23(3):259-62. PubMed ID: 15765041
[TBL] [Abstract][Full Text] [Related]
15. [Conservative treatment of chronic obstructive arterial disease with iloprost and physical training: assessment of results in 5 years of a study with 360 patients].
Apperti M; Masella A; Sabia D; Verde I
Ann Ital Chir; 2003; 74(4):453-7. PubMed ID: 14971289
[TBL] [Abstract][Full Text] [Related]
16. Long-term Clinical Results after Iloprost Treatment for Bone Marrow Edema and Avascular Necrosis.
Claßen T; Becker A; Landgraeber S; Haversath M; Li X; Zilkens C; Krauspe R; Jäger M
Orthop Rev (Pavia); 2016 Mar; 8(1):6150. PubMed ID: 27114807
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of iloprost for the treatment of ischaemic digits in paediatric connective tissue diseases.
Zulian F; Corona F; Gerloni V; Falcini F; Buoncompagni A; Scarazatti M; Martini G; Zacchello F
Rheumatology (Oxford); 2004 Feb; 43(2):229-33. PubMed ID: 12923288
[TBL] [Abstract][Full Text] [Related]
18. The management of necrosis-associated and idiopathic bone-marrow oedema of the proximal femur by intravenous iloprost.
Disch AC; Matziolis G; Perka C
J Bone Joint Surg Br; 2005 Apr; 87(4):560-4. PubMed ID: 15795211
[TBL] [Abstract][Full Text] [Related]
19. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia.
te Winkel ML; Appel IM; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2008 Oct; 93(10):1570-4. PubMed ID: 18698082
[TBL] [Abstract][Full Text] [Related]
20. Osteonecrosis in paediatric patients with acute lymphoblastic leukaemia treated on Co-ALL-07-03 trial: a single centre analysis.
Kuhlen M; Moldovan A; Krull K; Meisel R; Borkhardt A
Klin Padiatr; 2014 May; 226(3):154-60. PubMed ID: 24710762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
